Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthy Extracts (HYEX) Debt to Equity (2016 - 2022)

Healthy Extracts' Debt to Equity history spans 7 years, with the latest figure at $0.05 for Q3 2022.

  • For Q3 2022, Debt to Equity fell 70.04% year-over-year to $0.05; the TTM value through Sep 2022 reached $0.05, down 70.04%, while the annual FY2021 figure was $0.07, 15.51% up from the prior year.
  • Debt to Equity reached $0.05 in Q3 2022 per HYEX's latest filing, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $4.31 in Q1 2019 to a low of -$30.48 in Q2 2019.
  • Average Debt to Equity over 5 years is -$1.78, with a median of $0.05 recorded in 2022.
  • Peak YoY movement for Debt to Equity: plummeted 38907.82% in 2019, then surged 86179.66% in 2021.
  • A 5-year view of Debt to Equity shows it stood at -$0.08 in 2018, then plummeted by 1453.54% to -$1.21 in 2019, then soared by 104.93% to $0.06 in 2020, then grew by 15.51% to $0.07 in 2021, then fell by 25.21% to $0.05 in 2022.
  • Per Business Quant, the three most recent readings for HYEX's Debt to Equity are $0.05 (Q3 2022), $0.01 (Q2 2022), and $0.21 (Q1 2022).